IP Library Granted Patent US 12,674,752
Granted Patent B2
US 12,674,752 · App. 18/574,571 · Granted Jul 7, 2026

Rapid detection and identification of bacteria directly from whole blood with light scattering spectroscopy based biosensor

Inventor: Lev T. Perelman (Brookline, MA)
Assignee: Beth Israel Deaconess Medical Center, Inc.
G01N21/51C12Q1/04G01N33/49G01N2021/4704G01N2201/0683
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,674,752
App. No.
18/574,571
Filed
Dec 27, 2023
Granted
Jul 7, 2026
Kind
B2
Art Unit
2877
USPC
356/39
Abstract

Methods for identifying bacterial species in biofluid samples (e.g., whole blood samples) are described. The methods rely on optical spectroscopy, and enable rapid detection and identification of bacteria directly from whole blood. Not only can LSS-based techniques detect and identify bacteria in biofluids such as whole blood, but that species-level identification can potentially be made based on a small number of bacterial cells, without the need for observing entire colonies or performing susceptibility testing. The methods may comprise illuminating the biofluid sample with input light, detecting scattered light produced by the biofluid sample in response to the illuminating, generating first data indicative of a measured scattering spectrum associated with the biofluid sample using the detected scattered light, and identifying whether at least one of the bacterial species is present in the biofluid sample using the first data.

Claims (38)

1 . A method for identifying bacterial species in a biofluid sample, comprising:

illuminating the biofluid sample with input light;

detecting scattered light produced by the biofluid sample in response to the illuminating;

generating first data indicative of a measured scattering spectrum associated with the biofluid sample using the detected scattered light; and

identifying whether at least one of the bacterial species is present in the biofluid sample using the first data, wherein identifying whether at least one of the bacterial species is present in the biofluid sample comprises:

obtaining second data indicative of a plurality of reference scattering spectra, each reference scattering spectrum being associated with a respective one of the bacterial species;

generating third data indicative of a linear combination of the reference scattering spectra, the linear combination comprising a plurality of unknown coefficients representing respective concentrations for the bacterial species in the biofluid sample; and

determining the unknown coefficients using the first data and the third data.

2 . The method of claim 1 , wherein determining the unknown coefficients comprises generating an equation based on a comparison of the first data with the third data.

3 . The method of claim 2 , wherein determining the unknown coefficients comprises applying a linear minimization approach to the equation.

4 . The method of claim 1 , wherein identifying whether at least one of the bacterial species is present in the biofluid sample further comprises performing Rayleigh correction of the first data.

5 . The method of claim 1 , further comprising integrating the first data, wherein identifying whether at least one of the bacterial species is present in the biofluid sample further comprises identifying whether at least one of the bacterial species is present in the biofluid sample using the integrated first data.

6 . The method of claim 1 , wherein:

illuminating the biofluid sample with the input light comprises illuminating a blood sample with the input light; and

detecting the scattered light scattered by the biofluid sample in response to the illuminating comprises detecting the scattered light produced by the blood sample in response to the illuminating.

7 . The method of claim 1 , wherein illuminating the biofluid sample with the input light comprises illuminating the biofluid sample with polarized input light.

8 . The method of claim 7 , wherein the polarized input light is polarized in a direction substantially perpendicular to a scattering plane associated with the scattered light.

9 . The method of claim 1 , wherein detecting the scattered light produced by the biofluid sample comprises polarizing the scattered light and detecting the polarized scattered light.

10 . The method of claim 9 , wherein polarizing the scattered light comprises polarizing the scattered light in a direction substantially perpendicular to a scattering plane associated with the scattered light.

11 . The method of claim 1 , wherein identifying whether at least one of the bacterial species is present in the biofluid sample comprises identifying whether at least one of a Pseudomonas aeruginosa , an Escherichia coli , a Klebsiella pneumoniae , a Staphylococcus aureus , a Streptococcus pneumoniae , a Listeria monocytogenes , a Staphylococcus epidermidis , a Staphylococcus haemolyticus , a Neisseria meningitidis , a Haemophilus influenzae , and a Proteus mirabilis is present in the biofluid sample.

12 . The method of claim 1 , further comprising, prior to illuminating the biofluid sample with the input light, lysing red blood cells from the biofluid sample.

13 . The method of claim 12 , wherein the lysing the red blood cells from the biofluid sample comprises mixing the biofluid sample with water.

14 . The method of claim 1 , wherein identifying whether at least one bacterial species is present in the biofluid sample further comprises determining a relative concentration of the at least one bacterial species with respect to other bacterial species.

15 . A system for identifying bacterial species in a biofluid sample, comprising:

a light source;

a spectrograph and a photosensitive detector;

first and second polarizers, the first polarizer being disposed on a first optical path formed between the light source and the biofluid sample and the second polarizer being disposed on a second optical path formed between the biofluid sample and the spectrograph; and

a processor coupled to the photosensitive detector and configured to:

generate first data indicative of a measured scattering spectrum associated with the biofluid sample; and

identify whether at least one of the bacterial species is present in the biofluid sample using the first data, wherein the processor is configured to identify whether at least one of the bacterial species is present in the biofluid sample by:

obtaining second data indicative of a plurality of reference scattering spectra, each reference scattering spectrum being associated with a respective one of the bacterial species;

generating third data indicative of a linear combination of the reference scattering spectra, the linear combination comprising a plurality of unknown coefficients representing respective concentrations for the bacterial species in the biofluid sample; and

determining the unknown coefficients using the first data and the third data.

16 . The system of claim 15 , wherein the processor is configured to determine the unknown coefficients by generating an equation based on a comparison of the first data with the third data.

17 . The system of claim 15 , wherein identifying whether at least one of the bacterial species is present in the biofluid sample further comprises performing Rayleigh correction of the first data.

18 . The system of claim 15 , wherein:

the first polarizer has a polarization axis substantially perpendicular to a scattering plane associated with scattered light produced by the biofluid sample in response to illumination by the light source, and

the second polarizer has a polarization axis substantially perpendicular to the scattering plane.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 15, 2024
From: PERELMAN, LEV T.
To: BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
Reel/Frame 067419/0209 →
Continuity (2)
Provisional Application 63218184 · Jul 2, 2021
Related Publication 20240288367A1 · Aug 29, 2024
References Cited (30)
US 4374644A · Armstrong · 1983 [cited by examiner]
US 20090047664A1 · Vullev · 2009 [cited by examiner]
US 20100035235A1 · Gabriel · 2010 [cited by applicant]
US 20200297266A1 · Perelman · 2020 [cited by applicant]
US 20210033592A1 · Ye · 2021 [cited by examiner]
US 20210041341A1 · Chen · 2021 [cited by examiner]
WO WO2013050744A1 · 2013 [cited by applicant]
WO WO2021262738A2 · 2021 [cited by examiner]
International Search Report and Written Opinion for International Application No. PCT/US2022/035960, mailed Oct. 5, 2022. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/US2022/035960, mailed Jan. 11, 2024. [cited by applicant]
Bradley et al., Rapid antibiotic-resistance predictions from genome sequence data for [cited by applicant]
Chance et al., Carbohydrate sulfation effects on growth of Pseudomonas aeruginosa. Microbiology (Reading). Jul. 2000;146 (Pt 7):1717-25. doi: 10.1099/00221287-146-7-1717. [cited by applicant]
Cheng et al., Rapid (<5 min) Identification Of Pathogen In Human Blood by Electrokinetic Concentration and Surface-Enhanced Raman Spectroscopy. Sci Rep. Aug. 6, 2013;3:2365; 8 pages. doi: 10.1038/srep02365. [cited by applicant]
Depamphilis et al., Purification of intact flagella from [cited by applicant]
Drezek et al., Light scattering from cervical cells throughout neoplastic progression: influence of nuclear morphology, DNA content, and chromatin texture. J Biomed Opt. Jan. 2003;8(1):7-16. doi: 10.1117/1.1528950. [cited by applicant]
Han et al., Isolation of intact bacteria from blood by selective cell lysis in a microfluidic porous silica monolith. Microsyst Nanoeng. Jun. 17, 2019;5:30. 11 pages. doi: 10.1038/s41378-019-0063-4. [cited by applicant]
Itzkan et al., Confocal light absorption and scattering spectroscopic microscopy monitors organelles in live cells with no exogenous labels. Proc Natl Acad Sci U S A. Oct. 30, 2007;104(44):17255-60. doi: 10.1073/pnas.07… [cited by applicant]
Kang et al., Rapid detection of single bacteria in unprocessed blood using Integrated Comprehensive Droplet Digital Detection. Nat Commun. Nov. 13, 2014;5:5427. 10 pages. doi: 10.1038/ncomms6427. [cited by applicant]
Konokhova et al., High-precision characterization of individual [cited by applicant]
Layne et al., Transient fluorescence in synchronously dividing [cited by applicant]
Liu et al., Functionalized arrays of Raman-enhancing nanoparticles for capture and culture-free analysis of bacteria in human blood. Nat Commun. Nov. 15, 2011;2:538. 8 pages. doi: 10.1038/ncomms1546. [cited by applicant]
Männik et al., Robustness and accuracy of cell division in [cited by applicant]
Melo et al., Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. Nov. 10, 2014;26(5):707-21. doi: 10.1016/j.ccell.2014.09.005. Epub Oct. 23, 2014. [cited by applicant]
Mie G., Contributions on the Optics of Turbid Media, Particularly Colloidal Metal Solutions. InBook Annalen Der Physik. Series IV, 1908;25(3):377-445. [cited by applicant]
Onyango et al., Phenotypic variants of [cited by applicant]
Schubert et al., Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. J Mol Dia… [cited by applicant]
Silhavy et al., The bacterial cell envelope. Cold Spring Harb Perspect Biol. May 2010;2(5):a000414. 17 pages. doi: 10.1101/cshperspect.a000414. Epub Apr. 14, 2010. [cited by applicant]
Sinha et al., Emerging Technologies for Molecular Diagnosis of Sepsis. Clin Microbiol Rev. Apr. 2018;31(2):e00089-17. 26 pages. doi: 10.1128/CMR.00089-17. [cited by applicant]
Sokolov et al., Polarized reflectance spectroscopy for pre-cancer detection. Technol Cancer Res Treat. Feb. 2004;3(1):1-14. doi: 10.1177/153303460400300101. [cited by applicant]
Zheng et al., Optical Scatter Imaging with a digital micromirror device. Opt Express. Oct. 26, 2009;17(22):20401-14. doi: 10.1364/OE.17.020401. [cited by applicant]